|
|
Volumn 80, Issue 3, 2008, Pages e8-
|
|
Lanreotide Autogel® for persistent diabetic macular edema
|
|
Author keywords
Diabetes mellitus; Diabetic macular edema; Effectiveness; Quality of life; Somatostatin analogues
|
|
Indexed keywords
ANGIOPEPTIN;
CYCLOPEPTIDE;
DRUG DERIVATIVE;
SOMATOSTATIN;
ADULT;
ARTICLE;
CONTROLLED STUDY;
DIABETIC MACULAR EDEMA;
DRUG FORMULATION;
FEMALE;
FOLLOW UP;
HUMAN;
MAJOR CLINICAL STUDY;
QUALITY OF LIFE;
QUESTIONNAIRE;
VISUAL ACUITY;
AGED;
CASE REPORT;
DIABETIC ANGIOPATHY;
DRUG ADMINISTRATION;
GEL;
INJECTION;
MIDDLE AGED;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATHOLOGY;
RETINA FOVEA;
RETINA MACULA EDEMA;
AGED;
DIABETES MELLITUS, TYPE 2;
DIABETIC ANGIOPATHIES;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOVEA CENTRALIS;
GELS;
HUMANS;
INJECTIONS;
MACULAR EDEMA;
MIDDLE AGED;
PEPTIDES, CYCLIC;
QUALITY OF LIFE;
SOMATOSTATIN;
VISUAL ACUITY;
|
|
EID: 43049164317
PISSN: 01688227
EISSN: None
Source Type: Journal
DOI: 10.1016/j.diabres.2008.02.007 Document Type: Article |
|
Times cited : (8)
|
|
References (4)
|
